ACB $8.300 (-3.6%)

ACNNF $0.265 (0.04%)

AERO $1.160 (-13.43%)

AGEEF $0.540 (1.94%)

ALEAF $1.220 (-0.8%)

AMMJ $0.337 (2.12%)

APHA $6.475 (-3.93%)

ARNA $53.930 (-1.23%)

ATT:CNX $0.080 (0%)

ATTBF $0.032 (-11.2%)

AUSA:CNX $1.090 (-1.8%)

AUSAF $0.840 (-4.55%)

AVXL $3.595 (-2.84%)

BAMM:CNX $2.220 (0%)

BBM:CNX $0.550 (-1.79%)

BBRRF $0.421 (-7.17%)

BE:CNX $0.095 (5.56%)

BIO:CNX $0.590 (0%)

BLEVF $0.068 (-0.12%)

BLIS:CNX $0.415 (-3.49%)

BLO:CNX $1.150 (0%)

BLOZF $0.874 (-1.58%)

BUDZ $0.713 (-2.4%)

BXNG $0.535 (8.08%)

CADMF $1.456 (3.26%)

CALI:CNX $0.125 (0%)

CANN $1.640 (4.46%)

CARA $18.950 (-0.26%)

CBII:CNX $0.265 (-1.85%)

CBWTF $0.620 (0.38%)

CGC $44.510 (-3.28%)

CGRW $0.545 (0.93%)

CHOO:CNX $0.480 (-2.04%)

CHOOF $0.369 (-2.84%)

CNAB $0.420 (10.24%)

CNBX $0.300 (-4.9%)

CNGGF $1.560 (-0.95%)

CODI $16.384 (-0.34%)

CPMD $1.830 (4.57%)

CRBP $7.310 (-1.22%)

CRON $16.130 (3.4%)

CROP:CNX $0.265 (-3.64%)

CRXPF $0.201 (-4.29%)

CSI:CNX $1.860 (-5.1%)

CTST $5.660 (-4.07%)

CURR $4.000 (0%)

CVSI $4.700 (1.51%)

CWEB:CNX $19.980 (-4.63%)

DIGP $0.154 (1.89%)

DXBRF $0.812 (10.33%)

EAPH $0.008 (-1.23%)

EAT:CNX $0.220 (0%)

EEVVF $0.282 (-3.17%)

EMHTF $2.780 (1.83%)

EPWCF $0.140 (11.92%)

EVIO $0.390 (-2.5%)

FFRMF $0.085 (0%)

FFT:CNX $0.110 (-4.35%)

FNNZF $0.089 (-13.29%)

FSDDF $0.179 (2.05%)

GGTTF $0.459 (3.45%)

GLDFF $0.078 (0%)

GLH:CNX $0.105 (0%)

GLNNF $0.112 (-0.71%)

GNBT $1.020 (-7.26%)

GRIN:CNX $0.290 (3.57%)

GRWG $3.380 (-0.29%)

GTBIF $11.529 (-3.56%)

GTII:CNX $15.610 (1.1%)

GWPH $187.210 (1.74%)

HC:CNX $0.305 (0%)

HEXO $6.575 (-4.57%)

HHPHF $0.228 (-6.82%)

HLSPY $0.586 (22.49%)

HMLSF $15.191 (1.1%)

HMPPF $0.735 (0.07%)

HRVOF $0.600 (0.15%)

HSTRF $0.328 (0.95%)

HUGE:CNX $0.230 (0%)

IAN:CNX $5.310 (-2.93%)

IGC $1.040 (-7.14%)

IGXT $0.510 (0%)

IIPR $86.850 (-0.64%)

IMLFF $0.320 (-1.16%)

INQD $0.020 (-9.09%)

INSY $0.870 (-3.87%)

IONC:CNX $0.420 (-4.55%)

ISOL:CNX $1.110 (6.73%)

ISOLF $0.790 (2.73%)

ITHUF $4.080 (-0.46%)

IVITF $0.385 (-1.33%)

JWCAF $0.638 (-4.14%)

KALTF $0.036 (-6.48%)

KBEV:CNX $0.405 (-3.57%)

KBEVF $0.313 (-0.53%)

KHRNF $2.410 (-0.41%)

KSHB $4.870 (-0.61%)

LDS:CNX $0.425 (-1.16%)

LDSYF $0.333 (-10%)

LHS:CNX $0.740 (0%)

LHSIF $0.560 (2.75%)

LIHT:CNX $0.200 (0%)

LIHTF $0.147 (-4.92%)

LOVE:CNX $0.170 (-2.86%)

LVWL:CNX $0.740 (0%)

LXLLF $0.751 (-25.64%)

LXRP $0.960 (-2.86%)

LXX:CNX $1.230 (-2.38%)

MCIG $0.069 (1.32%)

MDCL $3.160 (5.69%)

MEDIF $5.195 (0.87%)

MGWFF $0.105 (-8.7%)

MICWF $0.255 (-1.54%)

MJ:CNX $0.480 (-2.04%)

MJNA $0.072 (14.77%)

MNTR $0.340 (-2.86%)

MRRCF $0.700 (21.72%)

MWM:CNX $0.335 (-1.47%)

MYM:CNX $0.450 (-3.23%)

MYMMF $0.353 (-1.51%)

NCNNF $0.829 (-3.63%)

NDVAF $0.385 (3.19%)

NGW:CNX $0.385 (-2.53%)

NRXCF $0.060 (1.69%)

NSPDF $0.089 (-6.2%)

NTEC $5.130 (4.06%)

NVTQF $0.017 (7.98%)

NWKRF $0.420 (-4.93%)

NXGWF $0.290 (-9.38%)

NXTTF $0.646 (16.78%)

OH:CNX $11.110 (-2.11%)

ORHOF $8.427 (0.62%)

OWCP $0.032 (45.66%)

PHGI:CNX $0.465 (-3.13%)

PHGRF $0.357 (-2.39%)

PHVAF $0.460 (-5.95%)

PILL:CNX $0.750 (-6.25%)

PKG:CNX $0.240 (0%)

PLPRF $3.652 (0.43%)

PLUS:CNX $4.780 (-2.65%)

PMCB $0.039 (0%)

PNPL $0.980 (-2%)

POTN $0.095 (-12.52%)

PRCNF $0.100 (-16.67%)

PTNYF $0.185 (1.59%)

PUFXF $0.382 (4.66%)

QCA:CNX $0.210 (0%)

RDDTF $0.732 (-3.56%)

RLLVF $0.082 (-0.12%)

RMHB $0.083 (3.75%)

RQB:CNX $0.650 (1.56%)

RQHTF $0.165 (1.69%)

RVVQF $0.480 (4.35%)

SLNG:CNX $2.180 (0%)

SMG $88.270 (-1.24%)

SNN:CNX $4.110 (-2.38%)

SNNVF $3.110 (-0.46%)

SOL:CNX $2.300 (-3.36%)

SOLCF $1.780 (-1.2%)

SPLIF $0.169 (0.77%)

SPRWF $1.390 (-1.63%)

SRNA $0.044 (-2%)

STEM:CNX $2.250 (0%)

STMH $1.600 (-3.03%)

SUN:CNX $0.680 (-2.86%)

TBPMF $0.457 (1.37%)

TCAN:CNX $5.670 (-7.35%)

TDRYF $0.309 (0%)

TER:CNX $7.790 (-2.26%)

TGEN $3.400 (-0.87%)

TGIF:CNX $0.450 (0%)

TGIFF $0.339 (7.42%)

THC:CNX $0.290 (5.45%)

THCBF $0.205 (0.99%)

TLRY $46.240 (3.72%)

TOKI:CNX $0.150 (0%)

TRLFF $0.365 (-3.21%)

TRPX $3.300 (-1.49%)

TRSSF $5.916 (-0.41%)

TRTC $0.740 (-3.27%)

TURV $0.540 (-1.19%)

VBIO $0.220 (4.76%)

VIDA:CNX $0.590 (-6.35%)

VIN:CNX $0.520 (0%)

VPRB $0.065 (8.33%)

VRNDF $1.051 (-2.69%)

VRT:CNX $0.510 (0%)

VRTHF $0.376 (-3.22%)

VVCIF $0.515 (3.46%)

WAYL:CNX $0.740 (0%)

WDDMF $1.300 (-1.52%)

WLDFF $0.529 (2.16%)

XXII $2.115 (1.68%)

ZDPY $0.310 (-0.64%)

ZYNE $14.660 (-1.08%)

Technical420 Site Search

Returned 37 result(s).

Emblem Corp. Reports Strong Third Quarter 2018 Financial Results

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), a licensed producer of cannabis under the Cannabis Act through its wholly owned subsidiary Emblem Cannabis Corporation, is pleased to report financial and operating results for the three and nine months ended September 30, 2018. The strong results underscore the Company’s continued focus on…

Emblem finalizes agreement to launch Emblem Germany in joint venture with Acnos Pharma

Emblem Corp.  (TSXV: EMC, OTCQX:EMMBF), today announced that, through its wholly-owned subsidiary Emblem Cannabis Corporation, it has signed a definitive agreement with German pharmaceutical wholesaler Acnos Pharma GmbH in respect to launching a joint venture under the name “Emblem Germany” for the purpose of exporting Emblem-branded cannabis products from Canada into Germany.…

Emblem partners with DriveABLE to support research that evaluates impairment risk

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) today announced it has completed an equity investment in DriveABLE Assessment Centres Inc. (“DriveABLE”), a global leader in cognitive-based driving evaluations that measure the risk of impairment. Through this investment – to Emblem’s knowledge, the first of its kind in the cannabis space – Emblem…

Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), along with Canntab Therapeutics Limited (“Canntab”), today announced that they have achieved a milestone with regards to the development of a patent-pending oral…

Emblem and Natura Naturals announce termination of letter of intent

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and Natura Naturals Holdings Inc. (“Natura”) announced the termination of their letter of intent as of 5 p.m. EST…

Emblem launches Atmosphere, its first oral dose-metered spray

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today announced the launch of its first oral dose-metered spray, Emblem Atmosphere. Designed with patients’ needs in mind, Atmosphere ensures a precise dose…

Emblem Continues To Advance Operations Both Domestic and Abroad

During the last month, Emblem (EMC.V) (EMMBF) has come off its recent lows and has been trending higher.This rally was long overdue as the Canadian cannabis producer was trading at very oversold levels. Emblem has been very busy and has been laser focused on execution ahead of the opening of…

Emblem announces proposed investment in Compass Cannabis Clinic, owner of Starbuds Canada

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), today announced its intention to purchase approximately $1 million of units of 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic (“Compass”) at a price of $0.60 per Unit. Each Unit will consist of one common share in the capital of Compass and one-half of one common…

3 Cannabis Stocks Setting Up For Big Returns

Canada has been leading the global cannabis movement and we have been favorable on this opportunity. The country’s recreational cannabis market will open on October 17th and companies are working tirelessly ahead of this.Today, we have highlighted three Canadian cannabis companies that are levered to this opportunity and have been…

Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

Emblem Corp. (TSXV: EMC, OTCQX: EMMBF), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, announced today that it has entered into a five-year supply and preferred vendor agreement with 10330698 Canada Ltd. d/b/a Compass Cannabis Clinic to become…

Older Posts »

Search Again